The University of Messina, known colloquially as UniME, is a state university located in Messina, Sicily, Italy. Founded in 1548 by Pope Paul III, it was the world's first Jesuit college and today it is counted among the oldest universities in Italy.

During the past decade, University of Messina conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Messina" #1 sponsor was "University of Messina" with 22 trials, followed by "Ultragenyx Pharmaceutical Inc" with 2 trials sponsored, "Azienda Ospedaliera di Padova" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Gaetano Isola, DDS, PhD" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Messina" #1 collaborator was "University of Padova" with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator and "Barrow Neurological Institute" with 1 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "University of Messina" are "Periodontal Diseases" (6 trials), "Metabolic Disease" (3 trials), "Distal Myopathy With Rimmed Vacuoles" (2 trials), "Distal Myopathy, Nonaka Type" (2 trials) and "GNE Myopathy" (2 trials). Many other conditions were trialed in "University of Messina" in a lesser frequency.

Most popular intervention types in "University of Messina" are "Other" (14 trials), "Drug" (11 trials), "Device" (3 trials), "Diagnostic Test" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Observation" (4 trials), "Placebo" (2 trials), "0.9% NaCl" (1 trials), "25-OH-D vitamin" (1 trials) and "5-fluorouracil 4% (Tolak)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Messina" are 31 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Messina". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in University of Messina, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Messina, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".

University of Messina has several departments that took part in Clinical trials: "University Hospital" - 6 trials, "Department of Neurosurgery, University of Messina" - 2 trials